Postdoc: Advanced Bioelectronic Medicine & Synthetic Biology

ETH Zurich; Schweiz; Vor Ort; CHF 110.000 - 140.000; Vollzeit

Zusammenfassung

ETH Zurich's Department of Biosystems Science and Engineering (D-BSSE) in Basel invites exceptional candidates for a Postdoc position in advanced bioelectronic and electrical conversion research, bridging biology, engineering, and physical sciences. The group develops programmable cells and bioelectronic interfaces to achieve wireless, real‑time control of therapeutic protein expression.

The role combines synthetic biology, nanotechnology, and electrochemistry, offering translational

Qualifikationen

• We are seeking highly motivated applicants with a background in physics, material science, or chemistry.
• Ideally with expertise in bioelectronics or software simulations, or a strong willingness to acquire it, alongside solid knowledge of electrochemistry and materials chemistry.
• Candidates should be eager to collaborate closely with molecular biologists and bioengineers and demonstrate a strong academic record with the ambition to pursue a career in industrial R&D, or entrepreneurship.

Aufgaben

• Postdoctoral projects will combine catalyst engineering, computational simulation, bioelectrode device fabrication, and electrical engineering to develop bioelectronic interfaces enabling closed‑loop programming of cellular behaviour and real‑time monitoring of metabolic activity.
• There will also be opportunities to design novel bioelectronic implants and develop specialized control software

Kenntnisse

Physics background

Materials science

Chemistry

Bioelectronics

Software simulations

Ausbildung

PhD in physics, chemistry or materials science

Jobbeschreibung

ETH Zurich's Department of Biosystems Science and Engineering (D-BSSE) in Basel invites exceptional candidates for a Postdoc position in advanced bioelectronic and electrical conversion research, bridging biology, engineering, and physical sciences. The group develops programmable cells and bioelectronic interfaces to achieve wireless, real‑time control of therapeutic protein expression.

The role combines synthetic biology, nanotechnology, and electrochemistry, offering translational